Arca
Skip to content
Tools
Tools

Lymphoid malignancies

Drug research and approvals for lymphoid malignancies: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 624 studies of lymphoid malignancies are recruiting on ClinicalTrials.gov, and Health Canada has authorized 6 drug trials for it since 2013.

  • Recruiting worldwide: 624
  • Trials authorized in Canada: 6
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting now

Newest posted first, of 624 recruiting on ClinicalTrials.gov ↗

Trials authorized in Canada

Newest first; search them all in Canada trials
Feb 22, 2023An open-label, phase 1/2 study evaluating AVM0703 in patients with lymphoid malignancies (opal study)Dexamethasone (avm 0703)Avm Biotechnology, LLCPending
Nov 29, 2018A phase 2, open-label, monotherapy, multicenter study to evaluate the efficacy and safety of INCB054828 in subjects with myeloid/lymphoid neoplasms with FGFR1…Pemigatinib (INCB054828)IncyteClosed
Apr 29, 2016A phase 1, dose-escalation/dose-expansion study evaluating the safety, pharmacokinetics, and pharmacodynamic effects of orally administered CB-5083 in subjects…CB-5083Cleave BiosciencesOngoing
Jan 15, 2016A phase I/II study of pembrolizumab (MK-3475) in children with advanced melanoma or a PD-L1 positive advanced, relapsed or refractory solid tumor or lymphoma…KeytrudaMerck & Co. (MSD)Ongoing
Jun 13, 2014A phase I study evaluating safety, tolerability and pharmacokinetics of escalating doses of AGS67E given as monotherapy in subjects with refractory or relapsed…AGS67EAstellas PharmaClosed
Dec 12, 2013A phase 1b study evaluating the safety, pharmacokinetics, pharmacodynamics, and clinical activity of gs 9820 monotherapy and combination therapy in subjects…GS-9820 /rituximabGilead SciencesPending

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.